Lot no: A1013 Expiry date: 31 Oct 2021 No. of doses: 586,700 No. of doses per container: 10 Signature: Name of authorized person: NIK JUZAIMAH BINTI JUHARI Head of Product and Cosmetic Testing Section for Director of National Pharmaceutical Regulatory Agency (NPRA) Ministry of Health Malaysia Date: 2 July 2021
are to be submitted and deemed satisfactory by NPRA according to the timeline given. Apart from that, the PRH is required to monitor the safety profile of the registered vaccine and inform NPRA soonest possible of any untoward events. The PRH is also required to conduct all activities planned under the Risk Management Plan (RMP) as well as
Exhibit 10.13 Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. MANUFACTURING PRODUCT SCHEDULE #5997-02 –LARGE SCALE MANUFACTURING OF COVID-19 VACCINE DRUG SUBSTANCE
Picture from AstraZeneca. KUALA LUMPUR, July 2 — Malaysians vaccinated with AstraZeneca-Oxford’s Covid-19 vaccine may be barred from entering Europe, as the European Union’s (EU) Digital Covid Certificate — which came into force yesterday — only recognises EU-approved shots for free travel within the bloc. While the European Medicines.
network.punditarena.com - 2022 DISCLAIMER: All models on www.xxxcrowlimg.com adult site are 18 years or older. network.punditarena.com has a zero-tolerance policy against ILLEGAL pornography. All galleries and links are provided by 3rd parties. We have no control over the content of these pages. We take no responsibility for the content on any website which we link to, please use your own discretion while surfing the porn links.